A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components

NCT00819104 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
402
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AstraZeneca

Collaborators